Trial intelligence / Profile preview

Etomidate and propofol mixture for gastroscopy anesthesia in elderly patients with hypertension

ChiCTR2100042584Phase 4Completed

Sponsor
Shandong Second Medical University
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of etomidate and propofol in hypertension (HTN) (3 arms), sponsored by Shandong Second Medical University. Primary endpoints: blood pressure, heart rate and 2 more. Started Mar 2021; status: completed.

02

Drugs

etomidatepropofol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on ChiCTR2100042584.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100042584.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call